Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

Additional Advances in HNSCC: Immunotherapy & Targeted Treatments

Oncology Data Advisor

D. Wong

ASCO® 2024 H&N Cancer Highlights: Key Insights From Clinical Trials

2024 ASCO® Annual Meeting Insights Hub

K. Kerrigan

Best of ASCO® Los Angeles 2024: The PATHWay Trial - Adjuvant Pembro …

UCLA Health

D. Wong

Incurable HPV- Head & Neck Cancer: Panel Discussion

GRACE

J. Weiss, S. Patel, S. Sheth

ASCO® 2024 Review: Updates on Metastatic HNSCC

Nebraska Oncology Society

E. Sherman

2024 Advances in Thyroid Cancer Treatment

GRACE

J. Weiss, S. Patel, S. Sheth

ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advance…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

ASCO® 2024 Review: Updates on Locally Advanced HNSCC

Nebraska Oncology Society

E. Sherman

Understanding Differentiated Thyroid Cancer & Multidisciplinary Trea…

Sarimar Agosto Salgado

Year in Review: Precision Medicine

Vivek Subbiah

Challenging Thyroid Cancer Cases from USC to the Panel

Keck School of Medicine of USC

C. T. Nguyen, T. Angell

Expert Perspectives on Key Trial Insights and Treatment Updates in H…

Yale Cancer Center

B. Burtness